Dental amalgam and psychosocial status: The New England Children's Amalgam Trial

Journal of Dental Research

Volumn 87, Issue 5, 2008, Pages 470-474

  Bellinger, D C ^a   Trachtenberg, F ^b   Zhang, A ^b   Tavares, M ^c   Daniel, D ^d   McKinlay, S ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c FORSYTH INSTITUTE   (United States)

^d UNIVERSITY OF NORTHERN COLORADO   (United States)

Author keywords

Children; Dental amalgam; Psychosocial function; Randomized trial

Indexed keywords

DENTAL ALLOY; MERCURY; RESIN;

ANALYSIS OF VARIANCE; ARTICLE; BEHAVIOR DISORDER; BLOOD; CHEMICALLY INDUCED DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENTAL CARIES; DENTAL SURGERY; DRUG EFFECT; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MERCURIALISM; METHODOLOGY; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; URINE;

ANALYSIS OF VARIANCE; CHILD; CHILD BEHAVIOR; CHILD BEHAVIOR DISORDERS; COMPOSITE RESINS; DENTAL AMALGAM; DENTAL CARIES; DENTAL RESTORATION, PERMANENT; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAINE; MALE; MASSACHUSETTS; MERCURY; MERCURY POISONING; NEUROPSYCHOLOGICAL TESTS;

EID: 43749100453     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910808700504     Document Type: Article

References (32)

1. Achenbach T (1991). Manual for the Child Behavior Checklist/4-18 and 1991 Profile. Burlington, VT: University of Vermont Department of Psychiatry.
2. Aydin N, Karaoglanoglu S, Yigit A, Keles MS, Kirpinar I, Seven N (2003). Neuropsychological effects of low mercury exposure in dental staff in Erzurum, Turkey. Int Dent J 53:85-91.
3. Bagedahl-Strindlund M, Ilie M, Furhoff AK, Tomson Y, Larsson KS, Sandborgh-Englund G, et al. (1997). A multidisciplinary clinical study of patients suffering from illness associated with mercury release from dental restorations: psychiatric aspects. Acta Psychiatr Scand 96:475-482.
4. Bailer J, Rist F, Rudolf A, Staehle HJ, Eickholz P, Triebig G, et al. (2001). Adverse health effects related to mercury exposure from dental amalgam fillings: toxicological or psychological causes? Psychol Med 31:255-263.
5. Bellinger DC, Trachtenberg F, Barregard L, Tavares M, Cernichiari E, Daniel D, et al. (2006). Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial. J Am Med Assoc 295:1775-1783.
6. Bellinger DC, Daniel D, Trachtenberg F, Tavares M, McKinlay S (2007a). Dental amalgam restorations and children's neuropsychological function. The New England Children's Amalgam Trial. Environ Health Perspect 115:440-446.
7. Bellinger DC, Trachtenberg F, Daniel D, Zhang A, Tavares M, McKinlay S (2007b). A dose-effect analysis of children's exposure to dental amalgam and neuropsychological function: the New England Children's Amalgam Trial. J Am Dent Assoc 138:1210-1216.
8. Beltran-Aguilar ED, Barker LK, Canto MT, Dye BA, Gooch BF, Griffin SO, et al. (2005). Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis - United States, 1988-1994 and 1999-2002. MMWR Surveill Summ 54(3):1-43.
9. Bjorkman L, Pedersen NL, Lichtenstein P (1996). Physical and mental health related to dental amalgam fillings in Swedish twins. Community Dent Oral Epidemiol 24:260-267.
10. Bratel J, Haraldson T, Ottosson JO (1997). Potential side effects of dental amalgam restorations. (II). No relation between mercury levels in the body and mental disorders. Eur J Oral Sci 105:244-250.
11. Children's Amalgam Trial Study Group (2003). The Children's Amalgam Trial: design and methods. Controll Clin Trials 24:795-814.
12. DeRouen TA, Martin MD, Leroux BG, Townes BD, Woods JS, Leitão J, et al. (2006). Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. J Am Med Assoc 295:1784-1792.
13. Echeverria D, Woods JS, Heyer NJ, Rohlman DS, Farm FM, Bittner AC Jr, et al. (2005). Chronic low-level mercury exposure, BDNF polymorphism, and associations with cognitive and motor function. Neurotoxicol Teratol 27:781-796.
14. Echeverria D, Woods JS, Heyer NJ, Rohlman D, Farm FM, Li T (2006). The association between a genetic polymorphism of coproporphyrinogen oxidase, dental mercury exposure and neurobehavioral response in humans. Neurotoxicol Teratol 28:39-48.
15. Gottwald B, Traenckner I, Kupfer J, Ganss C, Eis D, Schill WB, et al. (2001). "Amalgam disease" - poisoning, allergy, or psychic disorder? Int J Hyg Environ Health 204:223-229.
16. Gottwald B, Kupfer J, Traenckner I, Ganss C, Gieler U (2002). Psychological, allergic, and toxicological aspects of patients with amalgam-related complaints. Psychother Psychosom 71:223-232.
17. Grandjean P, Guldager B, Larsen IB, Jorgensen PJ, Holmstrup P (1997). Placebo response in environmental disease. Chelation therapy of patients with symptoms attributed to amalgam fillings. J Occup Environ Med 39:707-714.
18. Herrstrom P, Hogstedt B (1993). Clinical study of oral galvanism: no evidence of toxic mercury exposure but anxiety disorder an important background factor. Scand J Dent Res 101:232-237.
19. Hornung RW, Reed LD (1990). Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 5:46-51.
20. Lai TJ, Liu X, Guo YL, Guo NW, Yu ML, Hsu CC, et al. (2002). A cohort study of behavioral problems and intelligence in children with high prenatal polychlorinated biphenyl exposure. Arch Gen Psychiatry 59:1061-1066.
21. Langworth S (1997). Experiences from the amalgam unit at Huddinge hospital - somatic and psychosomatic aspects. Scand J Work Environ Health 23(Suppl 3):65-67.
22. Langworth S, Bjorkman L, Elinder CG, Jarup L, Savlin P (2002). Multidisciplinary examinations of patients with illness attributed to dental fillings. J Oral Rehabil 29:705-713.
23. Lee KT, Mattson SN, Riley EP (2004). Classifying children with heavy prenatal alcohol exposure using measures of attention. J Int Neuropsychol Soc 10:271-277.
24. Lindh U, Hudecek R, Danersund A, Eriksson S, Lindvall A (2002). Removal of dental amalgam and other metal alloys supported by antioxidant therapy alleviates symptoms and improves quality of life in patients with amalgam-associated ill health. Neuro Endocrinol Lett 23:459-482.
25. National Research Council (2000). Toxicological effects of methylmercury. Washington, DC: National Academy Press.
26. Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB (1996). Bone lead levels and delinquent behavior. J Am Med Assoc 275:363-369.
27. Reynolds CR, Kamphaus RW (1992). BASC. Behavioral Assessment System for Children. Manual. Circle Pines, MN: American Guidance Service, Inc.
28. Schweikl H, Spagnuolo G, Schmalz G (2006). Genetic and cellular toxicology of dental resin monomers. J Dent Res 85:870-877.
29. Siblerud RL (1992). A comparison of mental health of multiple sclerosis patients with silver/mercury dental fillings and those with fillings removed. Psychol Rep 70:1139-1151.
30. Siblerud RL, Motl J, Kienholz E (1994). Psychometric evidence that mercury from silver dental fillings may be an etiological factor in depression, excessive anger, and anxiety. Psychol Rep 74:67-80.
31. Sood BG, Nordstrom-Bailey B, Covington C, Sokol RJ, Ager J, Janisse J, et al. (2005). Gender and alcohol moderate caregiver reported child behavior after prenatal cocaine. Neurotoxicol Teratol 27:191-201.
32. Zimmer H, Ludwig H, Bader M, Bailer J, Eickholz P, Staehle HJ, et al. (2002). Determination of mercury in blood, urine and saliva for the biological monitoring of an exposure from amalgam fillings in a group with self-reported adverse health effects. Int J Hyg Environ Health 205:205-211.